AI assistant
EXELIXIS, INC. — Director's Dealing 2020
May 9, 2020
30561_dirs_2020-05-08_beace03e-900a-4ee4-9fc8-940ddddaf394.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-05-08
Reporting Person: Haley Patrick J. (EVP, Commercial)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-08 | Common Stock | M | 21375 | $1.76 | Acquired | 139866 | Direct |
| 2020-05-08 | Common Stock | S | 21375 | $25.87 | Disposed | 118491 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-08 | Option (right to buy) | $1.76 | M | 21375 | Disposed | 2021-11-16 | Common Stock (21375.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 23539 | Indirect |
| Common Stock | 10648 | Indirect |
Footnotes
F1: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,618 shares of common stock acquired on April 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.79 to $25.88. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 7, 2020.
F4: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018